AVAH

$7.07

Market ClosedAs of Mar 17, 8:00 PM UTC

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$7.07
Potential Downside
3.3%
Whystock Fair Value$6.84
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.48B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
18.61
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.08
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.15

Recent News

Simply Wall St.
Mar 17, 2026

A Look At Aveanna Healthcare Holdings (AVAH) Valuation After Recent Share Price Weakness

Aveanna Healthcare Holdings: recent performance and valuation snapshot Aveanna Healthcare Holdings (AVAH) has been on many investors’ radars after recent share price weakness, including a 13% decline over the past month and a 22% drop over the past 3 months. That pullback contrasts with Aveanna’s latest reported fundamentals. The company reported annual revenue of US$2.29b and net income of US$75.46m, supported by a diversified home care platform spanning private duty services, home health...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 16, 2026

Gear Up for Aveanna (AVAH) Q4 Earnings: Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Aveanna (AVAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 2, 2026

Implied Volatility Surging for Aveanna Healthcare Stock Options

Investors need to pay close attention to AVAH stock based on the movements in the options market lately.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 2, 2026

RadNet (RDNT) Q4 Earnings and Revenues Surpass Estimates

RadNet (RDNT) delivered earnings and revenue surprises of +22.67% and +6.28%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 1, 2026

A Look At Aveanna Healthcare Holdings (AVAH) Valuation After Recent Share Price Pullback

Aveanna Healthcare Holdings (AVAH) has been drawing fresh attention after recent trading, with the share price at $7.36 and short term returns mixed across the past week, month, and past 3 months. See our latest analysis for Aveanna Healthcare Holdings. While the share price has pulled back recently, with a 30 day share price return of a 12.38% decline and a 90 day return of a 20.69% decline from US$7.36, the 1 year total shareholder return of 72.77% and a very large 3 year total shareholder...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.